1. Home
  2. VERA vs BBNX Comparison

VERA vs BBNX Comparison

Compare VERA & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$49.29

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Logo Beta Bionics Inc.

BBNX

Beta Bionics Inc.

HOLD

Current Price

$29.73

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VERA
BBNX
Founded
2016
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.3B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
VERA
BBNX
Price
$49.29
$29.73
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
11
Target Price
$67.67
$28.09
AVG Volume (30 Days)
1.8M
672.2K
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$88,570,000.00
Revenue This Year
N/A
$52.13
Revenue Next Year
N/A
$36.16
P/E Ratio
N/A
N/A
Revenue Growth
N/A
67.01
52 Week Low
$18.53
$8.89
52 Week High
$50.16
$32.71

Technical Indicators

Market Signals
Indicator
VERA
BBNX
Relative Strength Index (RSI) 81.16 56.71
Support Level $40.38 $28.00
Resistance Level $47.10 $30.50
Average True Range (ATR) 3.45 1.82
MACD 1.26 -0.26
Stochastic Oscillator 91.67 38.33

Price Performance

Historical Comparison
VERA
BBNX

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

About BBNX Beta Bionics Inc.

Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.

Share on Social Networks: